Feds Extend Prescription Drug Filing Deadline, Announce Relaxed Enforcement - Bim Group

Feds Extend Prescription Drug Filing Deadline, Announce Relaxed Enforcement


The Departments of Labor, Health and Human Services, and the Treasury (collectively, the Departments) last week issued an FAQ that relieved filing entities from the December 27, 2022, deadline for providing certain information.

The Departments understood many plans and carriers faced significant operational challenges in complying with the reporting requirements, including arranging and coordinating a plan’s submission across multiple reporting entities. The Departments also noted they were extending the deadline to allow filers to accurately classify, compile, and validate required submission data. The Departments will consider a plan or issuer to be compliant if they make a good faith submission of 2020 and 2021 data on or before January 31, 2023.

Many interested parties also had expressed fears that the new and complex reporting requirements would inevitably lead to errors and other failures despite good faith efforts to comply.  So, for the 2020 and 2021 data submissions that were to have been due by December 27, 2022, the Departments announced they will not take enforcement action against any plan or carrier that uses a good faith, reasonable interpretation of the regulations and the Prescription Drug Data Collection (RxDC) Reporting Instructions in making its initial submission.

In addition, to facilitate compliant submissions, the Departments clarified and simplified the reporting requirements for 2020 and 2021 data to allow:

  • Multiple submissions by the same reporting entity; thus, a reporting entity submitting for more than one plan or carrier may create more than one submission for a reference year, instead of including the data of all clients within a single set of lists and files for the year.
  • More than one reporting entity to submit the same data file type on behalf of the same plan or carrier, instead of having to consolidate all of the plan’s or carrier’s data into a single data file for each type of data.
  • A reporting entity submitting the required data, within each state and market segment, to aggregate at a less granular level than that used by the reporting entity that is submitting the total annual spending data as would have been required under final rules.

The Departments also stated that reporting entities may, but will not be required to, include national drug codes for vaccines in their data files. Further, reporting entities will not have to report a value for amounts not applied to the deductible or out-of-pocket maximum or prescription amounts not applied to the deductible or out-of-pocket maximum. The FAQ notes that a reporting entity should not remove these columns from data files but rather may leave the data fields in these columns blank.

The immediate relief is welcome, albeit late, but plans should still be vigilant in working to ensure their RxDC requirements are met by no later than January 31, if not already submitted. The Departments also noted that further relief would be announced, as they deem necessary, prior to the next filing deadline.



This information has been prepared for UBA by Fisher & Phillips LLP. It is general information and provided for educational purposes only. It is not intended to provide legal advice. You should not act on this information without consulting legal counsel or other knowledgeable advisors.

Recent Insights

January 30, 2023
HR Elements

HR Elements: Workplace Culture | Why Best Friends Have Benefits at Work

READ TIME: 3 MINUTES You likely remember your first work friend. They showed you the ropes and helped you navigate office politics. Today, research shows that work best friends are not just nice to have, but also play an essential role in employee engagement and retention. Fostering a buddy-friendly environment can reap benefits in many […]
Read more
January 26, 2023
Compliance Alert, DOL

DOL Announces 2023 Penalties for Health & Welfare Plan Compliance Errors

READ TIME: 4 MINUTES Since 2015, federal agencies have been required to annually review the laws and regulations they enforce to adjust applicable penalties for inflation. These adjustments, or so the theory goes, provide higher incentives for plan sponsors to ensure their benefit plans and programs remain compliant. Specifically, the U.S. Department of Labor (DOL) […]
Read more
January 18, 2023

Webinar: Shedding Light on Qualifying Events and Special Enrollment Periods

Tuesday, February 14, 2023 1 – 2PM CST Register Now Attend this month’s webinar to learn how, when, and why the Internal Revenue Service allows an employee to make midyear election changes. Gain insights into: Section 125 irrevocable plan elections Which family members are impacted by permitted changes, and the “family glitch” Common HR errors […]
Read more
January 18, 2023

IRS Grants Permanent 30-Day Extension to Providing Individual ACA Statements

READ TIME: 4 MINUTES ‘Tis the season for applicable large employers (ALEs) to scramble to meet their Affordable Care Act (ACA) obligation to provide full-time employees with individual statements that provide group health coverage information required to be filed with the IRS on Form 1095-C. Although the ACA generally requires ALEs to furnish individual statements […]
Read more